Get to know our clinical trials

Study to evaluate the efficacy, safety and tolerability of BMS-986278 in patients with idiopathic pulmonary fibrosis.

STUDY TO EVALUATE THE EFFICACY, SAFETY AND TOLERABILITY OF BMS-986278 IN PATIENTS WITH IDIOPATHIC PULMONARY FIBROSIS.

Imagen de la Dra. Arantza Campo Ezquibela, especialista en Neumología de la Clínica Universidad de Navarra. La Dra. Campo se dedica preferencialmente a la patología intersticial y vascular pulmonar y los trastornos respiratorios del sueño.
Dr. Arantza Campo Ezquibela Curriculum
Specialist Pneumology Department
Navarre headquarters
Status
In recruitment
headquarters
Pamplona/Madrid

Technical Summary

  • STUDY TO EVALUATE THE EFFICACY, SAFETY AND TOLERABILITY OF BMS-986278 IN PATIENTS WITH IDIOPATHIC PULMONARY FIBROSIS
  • Code EudraCT: 2023-503697-21-00
  • Protocol number: IM027-068
  • Promoter: Bristol Myers Squibb
  • Link to Clinical Trials

* The trials only admit a limited number of patients and are subject to inclusion and exclusion criteria. The specialist who assesses your case will inform you of the conditions required to participate in the clinical trial.

Imagen de un icono azul con un fonendoscopio o estetoscopio.

Do you want to participate in this trial?

Request an appointment for our specialists to assess whether you qualify for this clinical trial

I want to make an appointment
Imagen de un icono azul de un registro en el informe médico.

Do you prefer to send us your reports?

If you prefer, you can send us your medical information and our specialists will evaluate your case without the need to come to the Clinica.

I WANT TO REQUEST A SECOND OPINION